WSJ -- In perhaps another symbol of Pfizer’s belt-tightening, the drugmaker is putting up for sale a 580,000-square foot factory where it made its now-defunct inhaled insulin product, Exubera.
WSJ -- In perhaps another symbol of Pfizer’s belt-tightening, the drugmaker is putting up for sale a 580,000-square foot factory where it made its now-defunct inhaled insulin product, Exubera.
